SCHEMBL19793280

SCHEMBL19793280

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3cccc4c(-c5ccccc5)c5c(-c6ccc(-n7c8ccccc8c8cc(-c9ccccc9)ccc87)cc6)cccc5c(-c5ccccc5)c34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
KMT2A Q03164 2/20 0.38
TSPO P30536 3/20 0.38
HDAC4 P56524 1/20 0.38
EDNRA P25101 2/20 0.33
MAPK14 Q16539 1/20 0.33
EDNRB P24530 1/20 0.33
ALK Q9UM73 3/20 0.33
DNM1 Q05193 1/20 0.33
IL1R1 P14778 1/20 0.33
PDE6D O43924 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PTGER4 P35408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19793276 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL461369 0.92 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2ATSPO
SCHEMBL30007102 0.92 L3MBTL1 (0.52) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL19793270 0.92 L3MBTL1 (0.52) L3MBTL1KDM4EATMKMT2AHDAC4
SCHEMBL25941681 0.89 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2ATSPO
SCHEMBL25941374 0.89 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2ATSPO
SCHEMBL16787505 0.89 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2ATSPO
SCHEMBL19997831 0.89 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2ATSPO
SCHEMBL25941539 0.89 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2ATSPO
SCHEMBL15159193 0.89 L3MBTL1 (0.52) L3MBTL1KDM4EATMKMT2ATSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10559762-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-02-11 US disclosed
US-20190036036-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2019-01-31 US disclosed
US-20180026207-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-01-25 US disclosed
US-20180026207-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026207-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device FLI1, ESR1, TRPA1 L3MBTL1 68/4885KDM4E 2870/4885ATM 3814/4885
US-10559762-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device TEAD1, TEAD2, TRPA1 L3MBTL1 119/4885KDM4E 2538/4885ATM 1072/4885
US-20190036036-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device TEAD1, TEAD2, TRPA1 L3MBTL1 119/4885KDM4E 2538/4885ATM 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.